Shenzhen - Delayed Quote CNY

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)

Compare
44.18
+0.27
+(0.61%)
At close: January 24 at 3:04:36 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Wen Duo Wu President & Director -- -- 1974
Ms. Hui Zhou VP, General Counsel, Chief Compliance Officer & Director -- -- 1972
Mr. Liang Wang Vice President -- -- 1980

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Guanlan High-tech Park
No. 1, Guanqing Road Guanhu Street Longhua District
Shenzhen, 518110
China
86 755 8336 0999 https://www.999.com.cn
Sector: 
Healthcare
Full Time Employees: 
20,318

Description

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injections; formula granules; and anti-infective drugs. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. operate as a subsidiary of China Resources Pharmaceutical Group Limited

Corporate Governance

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

November 29, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

4540.T Tsumura & Co.
4,528.00
+0.33%
 
4887.T Sawai Group Holdings Co., Ltd.
2,027.00
+0.67%
 
600079.SS HUMANWELL HEALTHCARE
21.89
-0.27%
 
600085.SS TONGRENTANG
36.75
+0.14%
 
4521.T Kaken Pharmaceutical Co., Ltd.
4,292.00
+1.35%
 
4530.T Hisamitsu Pharmaceutical Co., Inc.
4,642.00
+0.04%
 
000963.SZ Huadong Medicine Co., Ltd
34.11
-0.93%
 
ALKEM.BO Alkem Laboratories Limited
5,026.80
-2.95%
 
000250.KQ Sam Chun Dang Pharm. Co., Ltd
172,000.00
-0.58%
 
002001.SZ Zhejiang NHU Company Ltd.
22.49
+0.40%